Nonsteroidal anti-inflammatory drugs during pregnancy

References

• Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 4th. ed. Williams and Wilkins, Baltimore, s 1994.
   Google Scholar
• Østensen M.
   Google Scholar
• Kramer WB, Saade G, Ou CN, et al. Placental transfer of sulindac and its active sulfide metabolite in humans. Am J Obstet Gynecol 1995; 172: 886–90.
   PubMed Web of Science ®Google Scholar
• Herz-Picciotto, I, Hopenhayn-Rich C. Golub M, et al. The risks and benefits of taking aspirin during pregnancy. Epidemiologic Rev 1990; 12: 108–48.
   PubMed Web of Science ®Google Scholar
• Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, Publishing Sciences group. Littleton, 1977; 286–95.
   Google Scholar
• Momma K, Takeuchi H. Constriction of the fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. Prostaglandins 1983; 26:631–43.
   PubMed Web of Science ®Google Scholar
• Veyver van den IB, Moise KJ, Ou CN, et al. The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus. Obstet Gynecol 1993; 82: 500–3.
   PubMed Web of Science ®Google Scholar
• Moise KJ, Huhta JC, Sharif DS, et al. Indomethacin in the treatment of preterm labor; effects on the fetal ductus arteriosus. N Engl J Med 1988; 319: 327–31.
   PubMed Web of Science ®Google Scholar
• Hickok DE, Hollenbach KA, Reilley SF, et al. The association between decreased anmiotic fluid and treatment with nonsteroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol 1989; 160: 1525–31.
   PubMed Web of Science ®Google Scholar
• Morales WJ, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: A randomized study. Am J Obstet Gynecol 1993; 169: 97–102.
   PubMed Web of Science ®Google Scholar
• Lewis RB, Schulman JD. Influence of acetylicsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 1973: 2: 1159–61.
   PubMed Web of Science ®Google Scholar
• Østensen M, Østensen H. Safety of nonsteroidal antiinflammatory drugs in pregnant patients with rheumatic disease. J Rheumatol 1996; 23: 1045–9.
   PubMed Web of Science ®Google Scholar
• Leitich H, Egarter C, Husslein A, et al. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 1997; 104: 450–9.
   PubMedGoogle Scholar
• Fishman P, Falach-Vaknin E, Sredni B. et al. Aspirin- interleukin-3 interrelationships in patients with antiphospholipid syndrome. Am J Repr Immunol 1996; 35: 80–4.
   PubMed Web of Science ®Google Scholar
• Di Sessa TG, Moretti ML. Khoury A, et al. Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy. Am J Gynecol 1994; 171: 891–900.
   Web of Science ®Google Scholar
• Kaaja R, Julkunen H, Viinikka L. et al. Production of prostacyclin and thromboxane in lupus pregnancies: Effect of small dose of aspirin. Obstet Gynecol 1993; 82: 327–31.
   Google Scholar
• Tulzer G, Gudmundsson S, Tews G, et al. Incidence of indomethacin-induced fetal ductal constriction. J Matern Fetal Invest 1992; 1: 267–9.
   Google Scholar
• Gerson A, Abbasi S, Johnson A, et al. Safety and efficacy of long-term tocolysis with indomethacin. Am J Perinatol 1990; 7: 71–4.
   PubMed Web of Science ®Google Scholar
• Besinger RE, Niebyl JR, Keyes WG. et al. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol 1991; 164: 981–8.
   PubMed Web of Science ®Google Scholar
• Csaba JF, Sulyok E. Ertl T. Clinical note: relationship of maternal treatment with indomethacin to persistence of fetal circulation. J Pediatr 1978; 92: 484.
   PubMed Web of Science ®Google Scholar
• Kirshon B, Moise KJ, Wasserstrum N. et al. Influence of short-term indomethacin therapy on fetal urine output. Obstet Gynecol 1988; 72: 51–3.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Davis RO, Baker RC. Indomethacin induced oligohydramnios. Am J Obstet Gynecol 1989; 160: 1196–7.
   PubMed Web of Science ®Google Scholar
• Cantor B, Tyler T, Nelson RM, et al. Oligohydramnios and transient neonatal anuria. J Reprod Med 1980; 24: 220–3.
   PubMed Web of Science ®Google Scholar
• Simeoni U, Messer J. Weisburd P. et al. Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors. Eur J Pediatr 1989; 148: 371–3.
   PubMed Web of Science ®Google Scholar
• Van den Heijden BJ, Carlus C. Narcy F. et al. Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol 1994; 171: 617–23.
   PubMed Web of Science ®Google Scholar
• Carlan SJ, O'Brian WF, O'Leary TD, et al. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor. Obstet Gynecol 1992; 79: 223–8.
   PubMed Web of Science ®Google Scholar
• Räsanen J, Jouppila P. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: A randomized study. Am J Obstet Gynecol 1995; 173: 20–5.
   PubMed Web of Science ®Google Scholar
• Carlan SJ, O'Brian WF, Jones MH, et al. Outpatient oral sulindac to prevent recurrence of preterm labor. Obstet Gynecol 1995; 85: 769–74.
   PubMed Web of Science ®Google Scholar
• Ng PC, Fung H, Yeung CK. Localised ileal perforation associated with antenatal sulindac and dexamethasone treatment. Pediatr Surg Int 1995; 10: 557–8.
   Web of Science ®Google Scholar
• Wilkinson AR, Aynsley-Green A, Mitchell MD. Persistent pulmonary hypertension and abnormal prostaglandin levels in preterm infants after maternal treatment with naproxen. Arch Dis Child 1979; 54: 942–5.
   PubMed Web of Science ®Google Scholar
• Alun-Jones E, Williams J. Hyponatriemia and fluid retention in a neonate associated with maternal naproxen overdose. Clin Toxicol 1986; 24: 257–60.
   Web of Science ®Google Scholar
• Barry WS, Meinziger MM, Howse CR. Ibuprofen overdose an exposure in utero: results from a postmarketing voluntary reporting system. Am J Med 1984; 77(1A): 35–9.
   PubMed Web of Science ®Google Scholar
• Hennessy MD, Livingston EC, Papagianos J et al. The incidence of ductal constriction and oligohydramnios during tocolytic therapy with ibuprofen (abstract). Am J Obstet Gynecol 1992; 166: 324.
   Google Scholar
• Wiggins DA, Elliott JP. Oligohydramnios in each sac of a triplet gestation caused by Motrin—fulfilling Kock's postulates. Am J Obstet Gynecol 1990; 162: 460–61.
   PubMed Web of Science ®Google Scholar
• Tramontana S, Allocca G. Caserta R, et al. The use of ketoprofen in threatened premature labor (In Italian). Minerva Gynecol 1979; 4: 291.
   Google Scholar
• Dubecq JP, Gonnet JM, Horovitz J, et al. Prevention of threatened premature delivery by ritodrine and ketoprofen association. (In French) Xeme Journee de Medicine perinatale, Deauville 1980; 383–5.
   Google Scholar
• Lianas B, Cavert MH, Apere H, et al. Les effets secondares du ketoprofene apres exposition intra-uterine. Interet du dosage plasmatique. Arch Pediatr 1996; 3: 248–53.
   PubMed Web of Science ®Google Scholar
• Netter JC, Choulot JJ, Dagues-Bie M, et al. Oligohydramnios and persistent pulmonary arterial hypertension after use of ketoprofen during pregnancy. Sem Hop Paris 1990; 66: 1953–1.
   Google Scholar
• Gouyon JB, Petion, AM, Sandra D, et al. Renal insufficiency in a preterm infant after intrauterine exposure to ketoprofen. Arch Fr Pediatr 1991; 48: 347–8.
   PubMedGoogle Scholar
• Labat L, Lianas B, Dermotes-Mainard F. et al. Accumulation of S-Ketoprofen in neonates after maternal administration of the racemate. Fundam Clin Pharmacol 1995; 9: 94.
   Google Scholar
• Mignot G, Bavoux F. En fin de grosesse. les AINS sont dangereux pour le foetus. Rev prescrire 1991; 11: 363–6.
   Google Scholar
• Valente MG, Graca LM, Doria JM. Imbicao do trabalho de parto prematura pelo diclofenac. Medico 1978; 87:245–7.
   Google Scholar
• Voyer LE. Drut R, Mendez JH. Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam. Pediatr Nephrol 1994; 8: 592–4.
   PubMed Web of Science ®Google Scholar
• Sawdy R, Slater D, Fisk N et al. Use of a cyclooxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 1997; 350: 265–6.
   PubMed Web of Science ®Google Scholar
• Luerti M, Parazzine F, Agarossi A, et al. Risk factors for respiratory distress syndrome in the newborn. Acta Obstet Gynecol Scand 1993; 72: 359–64.
   PubMed Web of Science ®Google Scholar
• Kanto WP, Wilson R, Breat GL. Perinatal events and necrotizing enterocolitis in premature infants. Am J Dis Child 1978; 141–67.
   Google Scholar